MedPath

Transcutaneous Electrical Nerve Stimulation Treatment of Renal Colic

Not Applicable
Completed
Conditions
Renal Colic
Interventions
Device: TENS
Device: placebo group
Registration Number
NCT03237208
Lead Sponsor
Adiyaman University Research Hospital
Brief Summary

The aim of the present trial was to investigate the analgesic efficacy and safety of Transcutaneous electrical nerve stimulation treatment in patients with renal colic within the emergency department.

Detailed Description

Renal colic, an intensely painful condition, is a common presenting complaint to the emergency department. Parenteral opioids, nonsteroidal anti-inflammatory drugs and acetaminophen are commonly used to provide relief from renal colic. The aim of the present trial was to investigate the analgesic efficacy and safety of Transcutaneous electrical nerve stimulation treatment in patients with renal colic within the emergency department.

Study Design and Setting: A prospective, randomized, double-blind, placebo controlled, single-center, clinical trial will be conducted in emergency department of a tertiary care university hospital.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  1. Adult patients with renal colic admitted to emergency department.
  2. Adult patients who were definitively diagnosed with acute renal colic due to urinary system stones using unenhanced computed abdominopelvic tomography
Exclusion Criteria
  1. Patients below 18 years of age
  2. Patients with haemodynamic instability, with fever (temperature=38°C [100.4°F]), with evidence of peritoneal inflammation,
  3. Patients using any analgesic within the previous 48 hours of emergency department presentation
  4. Patients who declined to participate

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
TENSTENSPatients receiving the real transcutaneous electrical nerve stimulation (TENS) with 100 hertz, pulse width 200 microseconds, voltage 2 milliampere
placebo groupplacebo groupPatients receiving the application of transcutaneous electrical nerve stimulation, but transcutaneous electrical nerve stimulation will not be activated.
Primary Outcome Measures
NameTimeMethod
Reduction of the intensity of pain0 minutes, 15 minutes and 30 minutes after taking Transcutaneous Electrical Nerve Stimulation application

Subjects will complete 100 mm visual analog scales at time zero, 15 and 30 minutes after taking Transcutaneous Electrical Nerve Stimulation application

Secondary Outcome Measures
NameTimeMethod
Adverse events30 minutes after

30 minutes after taking Transcutaneous Electrical Nerve Stimulation application

Trial Locations

Locations (1)

Adiyaman University Research Hospital

🇹🇷

Adıyaman, Central, Turkey

© Copyright 2025. All Rights Reserved by MedPath